Home/Filings/4/0000891293-16-000170
4//SEC Filing

CTI BIOPHARMA CORP 4

Accession 0000891293-16-000170

CIK 0000891293operating

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 5:21 PM ET

Size

4.7 KB

Accession

0000891293-16-000170

Insider Transaction Report

Form 4
Period: 2016-06-30
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2016-06-30$0.29/sh+5,000$1,445305,000 total
Footnotes (1)
  • [F1]Shares acquired under the CTI BioPharma Corp. 2007 Employee Stock Purchase Plan.

Issuer

CTI BIOPHARMA CORP

CIK 0000891293

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000891293

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:21 PM ET
Size
4.7 KB